November 20, 2024 – Page 5

Insiders Updates

Investing in Phillips 66 (PSX) Is Getting More Attractive

Phillips 66’s recent filing unveils that its Exec. VP and CFO Mitchell Kevin J unloaded Company’s shares for reported $4.17

Analysts Viewpoint

Investing in CarParts.com Inc (PRTS): What You Must Know

In a filing, CarParts.com Inc revealed its Director BARNES JIM acquired Company’s shares for reported $0.1 million on Jun 11

Stock Earnings

Phunware Inc [PHUN] Chief Executive Officer makes an insider sale of 6,000 shares worth $34004.0.

Phunware Inc’s filing revealed that its Chief Executive Officer Snavely Michael unloaded Company’s shares for reported $34004.0 on Jul 12

Insiders Updates

A company insider recently sold 16,041 shares of Aldeyra Therapeutics Inc [ALDX]. Should You also Consider to Sale?

Aldeyra Therapeutics Inc’s recently made public that its Chief Development Officer Machatha Stephen unloaded Company’s shares for reported $75975.0 on

Analysts Viewpoint

Expedia Group Inc [EXPE] stock was sold by Soliday Lance A at the price of US$1.27 million

Expedia Group Inc’s recent filing unveils that its SVP & Chief Accounting Officer Soliday Lance A unloaded Company’s shares for

Stock Earnings

S’s latest rating updates from top analysts.

In a filing, SentinelOne Inc revealed its President, CEO Weingarten Tomer unloaded Company’s shares for reported $1.71 million on Nov

Insiders Updates

Analysts review Inspire Medical Systems Inc’s rating

Inspire Medical Systems Inc’s filing revealed that its Chief Technology Officer Rondoni John unloaded Company’s shares for reported $1.68 million

Analysts Viewpoint

SILO Pharma Inc’s latest rating changes from various analysts

SILO Pharma Inc’s recently made public that its CEO and President Weisblum Eric acquired Company’s shares for reported $4926.0 on

Stock Earnings

Lumentum Holdings Inc (LITE) receives a Buy rating from Needham

Lumentum Holdings Inc’s recent filing unveils that its Committee Member HERSCHER PENNY acquired Company’s shares for reported $0.18 million on

Insiders Updates

Recursion Pharmaceuticals Inc (RXRX) rating initates by Morgan Stanley

In a filing, Recursion Pharmaceuticals Inc revealed its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.15 million

Day: November 20, 2024